Loading provider…
Loading provider…
Internal Medicine Physician in Murphysboro, IL
NPI: 1003143801Primary Practice Location
ST JOSEPH MEMORIAL HOSPITAL
2 S Hospital Dr, Murphysboro, IL
Primary Employer
Synergy Integrative Headache Center Ltd
synergyheadache.com
HQ Phone
Get MD Alexander's Phone NumberMobile
Get MD Alexander's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
FL State Medical License
2023
CA State Medical License
2022 - 2026
IL State Medical License
2009 - 2026
OH State Medical License
2008 - 2011

National Board of Physicians and Surgeons
Internal Medicine

American Board of Pain Medicine
Pain Medicine

American Board of Medical Subspecialties
Headache Medicine
Cleveland Clinic Foundation
Fellowship • Pain Medicine
2010 - 2011
Ascension Illinois/Saint Joseph (Chicago)
Residency • Internal Medicine
2007 - 2010
IM Sechenov Moscow Medical Academy
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 65 | 197 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 34 | 34 |
| 3 | J0585Injection, onabotulinumtoxina, 1 unit | 27 | 6,159 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 27 | 32 |
| 5 | 64615Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 24 | 52 |
Authors: Diamond, Seymour, Freitag, Fred G, Feoktistov, Alexander, Nissan, George
Journal: J Headache Pain
Publication Date: 2007-01-15
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers.
Authors: Denise Chou, Jack Schim, Karen Yang, Shivang Joshi, Zubair Ahmed
Publication Date: 2021-02-05
Lead Sponsor: Amgen
Collaborators: Novartis
Intervention / Treatment: DRUG: Oral Prophylactic, DRUG: AMG334
Lead Sponsor: ElectroCore INC
Intervention / Treatment: DEVICE: gammaCore Sapphire active, DEVICE: gammaCore Sapphire Sham
Lead Sponsor: Autonomic Technologies, Inc.
Intervention / Treatment: DEVICE: ATI Neurostimulation System